Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.

OBJECTIVE: To investigate discriminating protein patterns and serum biomarkers between clear cell renal cell carcinoma (ccRCC) patients and healthy controls, as well as between paired pre- and post-operative ccRCC patients. METHODS: We used magnetic bead-based separation followed by matrix-assisted...

Full description

Bibliographic Details
Main Authors: Juan Yang, Jin Yang, Yan Gao, Lingyu Zhao, Liying Liu, Yannan Qin, Xiaofei Wang, Tusheng Song, Chen Huang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4219714?pdf=render
_version_ 1811273318328696832
author Juan Yang
Jin Yang
Yan Gao
Lingyu Zhao
Liying Liu
Yannan Qin
Xiaofei Wang
Tusheng Song
Chen Huang
author_facet Juan Yang
Jin Yang
Yan Gao
Lingyu Zhao
Liying Liu
Yannan Qin
Xiaofei Wang
Tusheng Song
Chen Huang
author_sort Juan Yang
collection DOAJ
description OBJECTIVE: To investigate discriminating protein patterns and serum biomarkers between clear cell renal cell carcinoma (ccRCC) patients and healthy controls, as well as between paired pre- and post-operative ccRCC patients. METHODS: We used magnetic bead-based separation followed by matrix-assisted laser desorption ionization (MALDI) time-of-flight (TOF) mass spectrometry (MS) to identify patients with ccRCC. A total of 162 serum samples were analyzed in this study, among which there were 58 serum samples from ccRCC patients, 40 from additional paired pre- and post-operative ccRCC patients (n = 20), and 64 from healthy volunteers as healthy controls. ClinProTools software identified several distinct markers between ccRCC patients and healthy controls, as well as between pre- and post-operative patients. RESULTS: Patients with ccRCC could be identified with a mean sensitivity of 88.38% and a mean specificity of 91.67%. Of 67 m/z peaks that differed among the ccRCC, healthy controls, pre- and post-operative ccRCC patients, 24 were significantly different (P<0.05). Three candidate peaks, which were upregulated in ccRCC group and showed a tendency to return to healthy control values after surgery, were identified as peptide regions of RNA-binding protein 6 (RBP6), tubulin beta chain (TUBB), and zinc finger protein 3 (ZFP3) with the m/z values of 1466.98, 1618.22, and 5905.23, respectively. CONCLUSION: MB-MALDI-TOF-MS method could generate serum peptidome profiles of ccRCC, and provide a new approach to identify potential biomarkers for diagnosis as well as prognosis of this malignancy.
first_indexed 2024-04-12T22:56:57Z
format Article
id doaj.art-82302d566a67420482295fe376b0c719
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T22:56:57Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-82302d566a67420482295fe376b0c7192022-12-22T03:13:09ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01911e11136410.1371/journal.pone.0111364Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.Juan YangJin YangYan GaoLingyu ZhaoLiying LiuYannan QinXiaofei WangTusheng SongChen HuangOBJECTIVE: To investigate discriminating protein patterns and serum biomarkers between clear cell renal cell carcinoma (ccRCC) patients and healthy controls, as well as between paired pre- and post-operative ccRCC patients. METHODS: We used magnetic bead-based separation followed by matrix-assisted laser desorption ionization (MALDI) time-of-flight (TOF) mass spectrometry (MS) to identify patients with ccRCC. A total of 162 serum samples were analyzed in this study, among which there were 58 serum samples from ccRCC patients, 40 from additional paired pre- and post-operative ccRCC patients (n = 20), and 64 from healthy volunteers as healthy controls. ClinProTools software identified several distinct markers between ccRCC patients and healthy controls, as well as between pre- and post-operative patients. RESULTS: Patients with ccRCC could be identified with a mean sensitivity of 88.38% and a mean specificity of 91.67%. Of 67 m/z peaks that differed among the ccRCC, healthy controls, pre- and post-operative ccRCC patients, 24 were significantly different (P<0.05). Three candidate peaks, which were upregulated in ccRCC group and showed a tendency to return to healthy control values after surgery, were identified as peptide regions of RNA-binding protein 6 (RBP6), tubulin beta chain (TUBB), and zinc finger protein 3 (ZFP3) with the m/z values of 1466.98, 1618.22, and 5905.23, respectively. CONCLUSION: MB-MALDI-TOF-MS method could generate serum peptidome profiles of ccRCC, and provide a new approach to identify potential biomarkers for diagnosis as well as prognosis of this malignancy.http://europepmc.org/articles/PMC4219714?pdf=render
spellingShingle Juan Yang
Jin Yang
Yan Gao
Lingyu Zhao
Liying Liu
Yannan Qin
Xiaofei Wang
Tusheng Song
Chen Huang
Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.
PLoS ONE
title Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.
title_full Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.
title_fullStr Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.
title_full_unstemmed Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.
title_short Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.
title_sort identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma
url http://europepmc.org/articles/PMC4219714?pdf=render
work_keys_str_mv AT juanyang identificationofpotentialserumproteomicbiomarkersforclearcellrenalcellcarcinoma
AT jinyang identificationofpotentialserumproteomicbiomarkersforclearcellrenalcellcarcinoma
AT yangao identificationofpotentialserumproteomicbiomarkersforclearcellrenalcellcarcinoma
AT lingyuzhao identificationofpotentialserumproteomicbiomarkersforclearcellrenalcellcarcinoma
AT liyingliu identificationofpotentialserumproteomicbiomarkersforclearcellrenalcellcarcinoma
AT yannanqin identificationofpotentialserumproteomicbiomarkersforclearcellrenalcellcarcinoma
AT xiaofeiwang identificationofpotentialserumproteomicbiomarkersforclearcellrenalcellcarcinoma
AT tushengsong identificationofpotentialserumproteomicbiomarkersforclearcellrenalcellcarcinoma
AT chenhuang identificationofpotentialserumproteomicbiomarkersforclearcellrenalcellcarcinoma